{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T09:34:08Z","timestamp":1792056848279,"version":"4.4.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2009,12,14]],"date-time":"2009-12-14T00:00:00Z","timestamp":1260748800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"},{"start":{"date-parts":[[2009,12,14]],"date-time":"2009-12-14T00:00:00Z","timestamp":1260748800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                        <jats:title>Introduction<\/jats:title>\n                        <jats:p>Tumor necrosis factor is a pleiotropic cytokine with potent immune regulatory functions. Although tumor necrosis factor inhibitors have demonstrated great utility in treating other autoimmune diseases, such as rheumatoid arthritis, there are conflicting results in Sj\u00f6gren's syndrome. The aim of this study was to assess the effect of a locally expressed tumor necrosis factor inhibitor on the salivary gland function and histopathology in an animal model of Sj\u00f6gren's syndrome.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Methods<\/jats:title>\n                        <jats:p>Using in vivo adeno associated viral gene transfer, we have stably expressed soluble tumor necrosis factor-receptor 1-Fc fusion protein locally in the salivary glands in the Non Obese Diabetic model of Sj\u00f6gren's syndrome. Pilocarpine stimulated saliva flow was measured to address the salivary gland function and salivary glands were analyzed for focus score and cytokine profiles. Additionally, cytokines and autoantibody levels were measured in plasma.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Results<\/jats:title>\n                        <jats:p>Local expression of tumor necrosis factor-receptor 1:immunoglobulin G fusion protein resulted in decreased saliva flow over time. While no change in lymphocytic infiltrates or autoantibody levels was detected, statistically significant increased levels of tumor growth factor-\u03b21 and decreased levels of interleukin-5, interleukin-12p70 and interleukin -17 were detected in the salivary glands. In contrast, plasma levels showed significantly decreased levels of tumor growth factor-\u03b21 and increased levels of interleukin-4, interferon-\u03b3, interleukin-10 and interleukin-12p70.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Conclusions<\/jats:title>\n                        <jats:p>Our findings suggest that expression of tumor necrosis factor inhibitors in the salivary gland can have a negative effect on salivary gland function and that other cytokines should be explored as points for therapeutic intervention in Sj\u00f6gren's syndrome.<\/jats:p>\n                     <\/jats:sec>","DOI":"10.1186\/ar2888","type":"journal-article","created":{"date-parts":[[2009,12,15]],"date-time":"2009-12-15T07:17:09Z","timestamp":1260861429000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Local expression of tumor necrosis factor-receptor 1:immunoglobulin G can induce salivary gland dysfunction in a murine model of Sj\u00f6gren's syndrome"],"prefix":"10.1186","volume":"11","author":[{"given":"Jelle L","family":"Vosters","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongen","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nienke","family":"Roescher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc R","family":"Kok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul P","family":"Tak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A","family":"Chiorini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,12,14]]},"reference":[{"key":"2717_CR1","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/S0140-6736(05)66990-5","volume":"366","author":"RI Fox","year":"2005","unstructured":"Fox RI: Sjogren's syndrome. Lancet. 2005, 366: 321-331. 10.1016\/S0140-6736(05)66990-5.","journal-title":"Lancet"},{"key":"2717_CR2","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1136\/ard.2004.022707","volume":"64","author":"NM Van Mello","year":"2005","unstructured":"Van Mello NM, Pillemer SR, Tak PP, Sankar V: B cell MALT lymphoma diagnosed by labial minor salivary gland biopsy in patients screened for Sjogren's syndrome. Ann Rheum Dis. 2005, 64: 471-473. 10.1136\/ard.2004.022707.","journal-title":"Ann Rheum Dis"},{"key":"2717_CR3","doi-asserted-by":"publisher","first-page":"15","DOI":"10.2169\/internalmedicine.42.15","volume":"42","author":"PC Taylor","year":"2003","unstructured":"Taylor PC: Anti-TNFalpha therapy for rheumatoid arthritis: an update. Intern Med. 2003, 42: 15-20. 10.2169\/internalmedicine.42.15.","journal-title":"Intern Med"},{"key":"2717_CR4","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.pharmthera.2007.10.001","volume":"117","author":"D Tracey","year":"2008","unstructured":"Tracey D, Klareskog L, Sasso EH, Salfeld JG, Tak PP: Tumor necrosis factor antagonist mechanisms of action: a comprehensive review. Pharmacol Ther. 2008, 117: 244-279. 10.1016\/j.pharmthera.2007.10.001.","journal-title":"Pharmacol Ther"},{"key":"2717_CR5","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/nri702","volume":"2","author":"JJ O'Shea","year":"2002","unstructured":"O'Shea JJ, Ma A, Lipsky P: Cytokines and autoimmunity. Nat Rev Immunol. 2002, 2: 37-45. 10.1038\/nri702.","journal-title":"Nat Rev Immunol"},{"key":"2717_CR6","first-page":"411","volume":"19","author":"M Garcic-Carrasco","year":"2001","unstructured":"Garcic-Carrasco M, Font J, Filella X, Cervera R, Ramos-Casals M, Siso A, Aymami A, Ballesta AM, Ingelmo M: Circulating levels of Th1\/Th2 cytokines in patients with primary Sjogren's syndrome: correlation with clinical and immunological features. Clin Exp Rheumatol. 2001, 19: 411-415.","journal-title":"Clin Exp Rheumatol"},{"key":"2717_CR7","doi-asserted-by":"crossref","first-page":"5532","DOI":"10.4049\/jimmunol.152.11.5532","volume":"152","author":"RI Fox","year":"1994","unstructured":"Fox RI, Kang HI, Ando D, Abrams J, Pisa E: Cytokine mRNA expression in salivary gland biopsies of Sjogren's syndrome. J Immunol. 1994, 152: 5532-5539.","journal-title":"J Immunol"},{"key":"2717_CR8","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1002\/art.20146","volume":"50","author":"X Mariette","year":"2004","unstructured":"Mariette X, Ravaud P, Steinfeld S, Baron G, Goetz J, Hachulla E, Combe B, Puechal X, Pennec Y, Sauvezie B, Perdriger A, Hayem G, Janin A, Sibilia J: Inefficacy of infliximab in primary Sjogren's syndrome: results of the randomized, controlled Trial of Remicade in Primary Sjogren's Syndrome (TRIPSS). Arthritis Rheum. 2004, 50: 1270-1276. 10.1002\/art.20146.","journal-title":"Arthritis Rheum"},{"key":"2717_CR9","doi-asserted-by":"publisher","first-page":"3301","DOI":"10.1002\/art.10674","volume":"46","author":"SD Steinfeld","year":"2002","unstructured":"Steinfeld SD, Demols P, Appelboom T: Infliximab in primary Sjogren's syndrome: one-year followup. Arthritis Rheum. 2002, 46: 3301-3303. 10.1002\/art.10674.","journal-title":"Arthritis Rheum"},{"key":"2717_CR10","doi-asserted-by":"publisher","first-page":"12287","DOI":"10.1073\/pnas.172382999","volume":"99","author":"AJ Wu","year":"2002","unstructured":"Wu AJ, Hua H, Munson SH, McDevitt HO: Tumor necrosis factor-alpha regulation of CD4+CD25+ T cell levels in NOD mice. Proc Natl Acad Sci USA. 2002, 99: 12287-12292. 10.1073\/pnas.172382999.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2717_CR11","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1007\/s00018-005-5022-6","volume":"62","author":"S Kodama","year":"2005","unstructured":"Kodama S, Davis M, Faustman DL: The therapeutic potential of tumor necrosis factor for autoimmune disease: a mechanistically based hypothesis. Cell Mol Life Sci. 2005, 62: 1850-1862. 10.1007\/s00018-005-5022-6.","journal-title":"Cell Mol Life Sci"},{"key":"2717_CR12","doi-asserted-by":"publisher","first-page":"2240","DOI":"10.1002\/art.20299","volume":"50","author":"V Sankar","year":"2004","unstructured":"Sankar V, Brennan MT, Kok MR, Leakan RA, Smith JA, Manny J, Baum BJ, Pillemer SR: Etanercept in Sjogren's syndrome: a twelve-week randomized, double-blind, placebo-controlled pilot clinical trial. Arthritis Rheum. 2004, 50: 2240-2245. 10.1002\/art.20299.","journal-title":"Arthritis Rheum"},{"key":"2717_CR13","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1136\/ard.2007.077891","volume":"67","author":"NM Moutsopoulos","year":"2008","unstructured":"Moutsopoulos NM, Katsifis GE, Angelov N, Leakan RA, Sankar V, Pillemer S, Wahl SM: Lack of efficacy of etanercept in Sjogren syndrome correlates with failed suppression of tumour necrosis factor alpha and systemic immune activation. Ann Rheum Dis. 2008, 67: 1437-1443. 10.1136\/ard.2007.077891.","journal-title":"Ann Rheum Dis"},{"key":"2717_CR14","doi-asserted-by":"publisher","first-page":"3995","DOI":"10.1002\/art.23062","volume":"56","author":"CP Mavragani","year":"2007","unstructured":"Mavragani CP, Niewold TB, Moutsopoulos NM, Pillemer SR, Wahl SM, Crow MK: Augmented interferon-alpha pathway activation in patients with Sjogren's syndrome treated with etanercept. Arthritis Rheum. 2007, 56: 3995-4004. 10.1002\/art.23062.","journal-title":"Arthritis Rheum"},{"key":"2717_CR15","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1089\/104303403322542257","volume":"14","author":"MR Kok","year":"2003","unstructured":"Kok MR, Yamano S, Lodde BM, Wang J, Couwenhoven RI, Yakar S, Voutetakis A, Leroith D, Schmidt M, Afione S, Pillemer SR, Tsutsui MT, Tak PP, Chiorini JA, Baum BJ: Local adeno-associated virus-mediated interleukin 10 gene transfer has disease-modifying effects in a murine model of Sjogren's syndrome. Hum Gene Ther. 2003, 14: 1605-1618. 10.1089\/104303403322542257.","journal-title":"Hum Gene Ther"},{"key":"2717_CR16","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1136\/ard.2005.038232","volume":"65","author":"BM Lodde","year":"2006","unstructured":"Lodde BM, Mineshiba F, Wang J, Cotrim AP, Afione S, Tak PP, Baum BJ: Effect of human vasoactive intestinal peptide gene transfer in a murine model of Sjogren's syndrome. Ann Rheum Dis. 2006, 65: 195-200. 10.1136\/ard.2005.038232.","journal-title":"Ann Rheum Dis"},{"key":"2717_CR17","doi-asserted-by":"publisher","first-page":"6884","DOI":"10.1128\/JVI.75.15.6884-6893.2001","volume":"75","author":"N Kaludov","year":"2001","unstructured":"Kaludov N, Brown KE, Walters RW, Zabner J, Chiorini JA: Adeno-associated virus serotype 4 (AAV4) and AAV5 both require sialic acid binding for hemagglutination and efficient transduction but differ in sialic acid linkage specificity. J Virol. 2001, 75: 6884-6893. 10.1128\/JVI.75.15.6884-6893.2001.","journal-title":"J Virol"},{"key":"2717_CR18","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1084\/jem.174.6.1483","volume":"174","author":"K Peppel","year":"1991","unstructured":"Peppel K, Crawford D, Beutler B: A tumor necrosis factor (TNF) receptor-IgG heavy chain chimeric protein as a bivalent antagonist of TNF activity. J Exp Med. 1991, 174: 1483-1489. 10.1084\/jem.174.6.1483.","journal-title":"J Exp Med"},{"key":"2717_CR19","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/0022-1759(86)90322-4","volume":"95","author":"T Espevik","year":"1986","unstructured":"Espevik T, Nissen-Meyer J: A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor\/tumor necrosis factor from human monocytes. J Immunol Methods. 1986, 95: 99-105. 10.1016\/0022-1759(86)90322-4.","journal-title":"J Immunol Methods"},{"key":"2717_CR20","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.1089\/hum.1998.9.18-2745","volume":"9","author":"D Grimm","year":"1998","unstructured":"Grimm D, Kern A, Rittner K, Kleinschmidt JA: Novel tools for production and purification of recombinant adenoassociated virus vectors. Hum Gene Ther. 1998, 9: 2745-2760. 10.1089\/hum.1998.9.18-2745.","journal-title":"Hum Gene Ther"},{"key":"2717_CR21","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1126\/science.149.3685.754","volume":"149","author":"RW Atchison","year":"1965","unstructured":"Atchison RW, Casto BC, Hammon WM: Adenovirus-Associated Defective Virus Particles. Science. 1965, 149: 754-756. 10.1126\/science.149.3685.754.","journal-title":"Science"},{"key":"2717_CR22","doi-asserted-by":"publisher","first-page":"R862","DOI":"10.1186\/ar1757","volume":"7","author":"JJ Haringman","year":"2005","unstructured":"Haringman JJ, Vinkenoog M, Gerlag DM, Smeets TJ, Zwinderman AH, Tak PP: Reliability of computerized image analysis for the evaluation of serial synovial biopsies in randomized controlled trials in rheumatoid arthritis. Arthritis Res Ther. 2005, 7: R862-867. 10.1186\/ar1757.","journal-title":"Arthritis Res Ther"},{"key":"2717_CR23","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1002\/jgm.1053","volume":"9","author":"M Khoury","year":"2007","unstructured":"Khoury M, Adriaansen J, Vervoordeldonk MJ, Gould D, Chernajovsky Y, Bigey P, Bloquel C, Scherman D, Tak PP, Jorgensen C, Apparailly F: Inflammation-inducible anti-TNF gene expression mediated by intra-articular injection of serotype 5 adeno-associated virus reduces arthritis. J Gene Med. 2007, 9: 596-604. 10.1002\/jgm.1053.","journal-title":"J Gene Med"},{"key":"2717_CR24","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1136\/ard.2006.064519","volume":"66","author":"J Adriaansen","year":"2007","unstructured":"Adriaansen J, Khoury M, de Cortie CJ, Fallaux FJ, Bigey P, Scherman D, Gould DJ, Chernajovsky Y, Apparailly F, Jorgensen C, Vervoordeldonk MJ, Tak PP: Reduction of arthritis following intra-articular administration of an adeno-associated virus serotype 5 expressing a disease-inducible TNF-blocking agent. Ann Rheum Dis. 2007, 66: 1143-1150. 10.1136\/ard.2006.064519.","journal-title":"Ann Rheum Dis"},{"key":"2717_CR25","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/0030-4220(74)90417-4","volume":"37","author":"JS Greenspan","year":"1974","unstructured":"Greenspan JS, Daniels TE, Talal N, Sylvester RA: The histopathology of Sjogren's syndrome in labial salivary gland biopsies. Oral Surg Oral Med Oral Pathol. 1974, 37: 217-229. 10.1016\/0030-4220(74)90417-4.","journal-title":"Oral Surg Oral Med Oral Pathol"},{"key":"2717_CR26","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.2741\/2187","volume":"12","author":"CQ Nguyen","year":"2007","unstructured":"Nguyen CQ, Cha SR, Peck AB: Sjogren's syndrome (SjS)-like disease of mice: the importance of B lymphocytes and autoantibodies. Front Biosci. 2007, 12: 1767-1789. 10.2741\/2187.","journal-title":"Front Biosci"},{"key":"2717_CR27","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1191\/0961203305lu2240rr","volume":"14","author":"L De Rycke","year":"2005","unstructured":"De Rycke L, Baeten D, Kruithof E, Bosch Van den F, Veys EM, De Keyser F: The effect of TNFalpha blockade on the antinuclear antibody profile in patients with chronic arthritis: biological and clinical implications. Lupus. 2005, 14: 931-937. 10.1191\/0961203305lu2240rr.","journal-title":"Lupus"},{"key":"2717_CR28","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1186\/ar2341","volume":"10","author":"M Aringer","year":"2008","unstructured":"Aringer M, Smolen JS: The role of tumor necrosis factor-alpha in systemic lupus erythematosus. Arthritis Res Ther. 2008, 10: 202-10.1186\/ar2341.","journal-title":"Arthritis Res Ther"},{"key":"2717_CR29","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1111\/j.1365-2567.2008.02933.x","volume":"127","author":"S Masli","year":"2009","unstructured":"Masli S, Turpie B: Anti-inflammatory effects of tumour necrosis factor (TNF)-alpha are mediated via TNF-R2 (p75) in tolerogenic transforming growth factor-beta-treated antigen-presenting cells. Immunology. 2009, 127: 62-72. 10.1111\/j.1365-2567.2008.02933.x.","journal-title":"Immunology"},{"key":"2717_CR30","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.2353\/ajpath.2009.090319","volume":"175","author":"GE Katsifis","year":"2009","unstructured":"Katsifis GE, Rekka S, Moutsopoulos NM, Pillemer S, Wahl SM: Systemic and local interleukin-17 and linked cytokines associated with Sjogren's syndrome immunopathogenesis. Am J Pathol. 2009, 175: 1167-1177. 10.2353\/ajpath.2009.090319.","journal-title":"Am J Pathol"},{"key":"2717_CR31","doi-asserted-by":"publisher","first-page":"3633","DOI":"10.1002\/art.24980","volume":"60","author":"JL Vosters","year":"2009","unstructured":"Vosters JL, Landek-Salgado MA, Yin H, Swaim WD, Kimura H, Tak PP, Caturegli P, Chiorini JA: Interleukin-12 induces salivary gland dysfunction in transgenic mice, providing a new model of Sj\u00f6gren's syndrome. Arthritis Rheum. 2009, 60: 3633-3641. 10.1002\/art.24980.","journal-title":"Arthritis Rheum"},{"key":"2717_CR32","doi-asserted-by":"crossref","first-page":"3205","DOI":"10.4049\/jimmunol.155.6.3205","volume":"155","author":"H Dang","year":"1995","unstructured":"Dang H, Geiser AG, Letterio JJ, Nakabayashi T, Kong L, Fernandes G, Talal N: SLE-like autoantibodies and Sjogren's syndrome-like lymphoproliferation in TGF-beta knockout mice. J Immunol. 1995, 155: 3205-3212.","journal-title":"J Immunol"},{"key":"2717_CR33","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1212\/WNL.57.10.1885","volume":"57","author":"NL Sicotte","year":"2001","unstructured":"Sicotte NL, Voskuhl RR: Onset of multiple sclerosis associated with anti-TNF therapy. Neurology. 2001, 57: 1885-1888.","journal-title":"Neurology"},{"key":"2717_CR34","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1097\/01.mcg.0000155126.82171.32","volume":"39","author":"PJ Enayati","year":"2005","unstructured":"Enayati PJ, Papadakis KA: Association of anti-tumor necrosis factor therapy with the development of multiple sclerosis. J Clin Gastroenterol. 2005, 39: 303-306. 10.1097\/01.mcg.0000155126.82171.32.","journal-title":"J Clin Gastroenterol"},{"key":"2717_CR35","first-page":"2287","volume":"30","author":"SJ Jarrett","year":"2003","unstructured":"Jarrett SJ, Cunnane G, Conaghan PG, Bingham SJ, Buch MH, Quinn MA, Emery P: Anti-tumor necrosis factor-alpha therapy-induced vasculitis: case series. J Rheumatol. 2003, 30: 2287-2291.","journal-title":"J Rheumatol"},{"key":"2717_CR36","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1097\/MD.0b013e3181441a68","volume":"86","author":"M Ramos-Casals","year":"2007","unstructured":"Ramos-Casals M, Brito-Zeron P, Munoz S, Soria N, Galiana D, Bertolaccini L, Cuadrado MJ, Khamashta MA: Autoimmune diseases induced by TNF-targeted therapies: analysis of 233 cases. Medicine (Baltimore). 2007, 86: 242-251. 10.1097\/MD.0b013e3181441a68.","journal-title":"Medicine (Baltimore)"},{"key":"2717_CR37","doi-asserted-by":"publisher","first-page":"2300","DOI":"10.1002\/art.21945","volume":"54","author":"MV Jonsson","year":"2006","unstructured":"Jonsson MV, Delaleu N, Brokstad KA, Berggreen E, Skarstein K: Impaired salivary gland function in NOD mice: Association with changes in cytokine profile but not with histopathologic changes in the salivary gland. Arthritis Rheum. 2006, 54: 2300-2305. 10.1002\/art.21945.","journal-title":"Arthritis Rheum"},{"key":"2717_CR38","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1111\/j.1601-0825.2006.01241.x","volume":"12","author":"BM Lodde","year":"2006","unstructured":"Lodde BM, Mineshiba F, Kok MR, Wang J, Zheng C, Schmidt M, Cotrim AP, Kriete M, Tak PP, Baum BJ: NOD mouse model for Sjogren's syndrome: lack of longitudinal stability. Oral Dis. 2006, 12: 566-572. 10.1111\/j.1601-0825.2006.01241.x.","journal-title":"Oral Dis"},{"key":"2717_CR39","doi-asserted-by":"publisher","first-page":"113","DOI":"10.3109\/08916939609001952","volume":"24","author":"F Saravia-Fernandez","year":"1996","unstructured":"Saravia-Fernandez F, Durant S, Hasnaoui A, et al: Environmental and Experimental Procedures Leading to Variations in the Incidence of Diabetes in the Nonobese Diabetic (NOD) Mouse. Autoimmunity. 1996, 24: 113-121. 10.3109\/08916939609001952.","journal-title":"Autoimmunity"},{"key":"2717_CR40","doi-asserted-by":"publisher","first-page":"2566","DOI":"10.1002\/art.22826","volume":"56","author":"MS Soyfoo","year":"2007","unstructured":"Soyfoo MS, De Vriese C, Debaix H, Martin-Martinez MD, Mathieu C, Devuyst O, Steinfeld SD, Delporte C: Modified aquaporin 5 expression and distribution in submandibular glands from NOD mice displaying autoimmune exocrinopathy. Arthritis Rheum. 2007, 56: 2566-2574. 10.1002\/art.22826.","journal-title":"Arthritis Rheum"},{"key":"2717_CR41","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1016\/j.molimm.2005.09.003","volume":"43","author":"C Nguyen","year":"2006","unstructured":"Nguyen C, Cornelius J, Singson E, Killedar S, Cha S, Peck AB: Role of complement and B lymphocytes in Sjogren's syndrome-like autoimmune exocrinopathy of NOD.B10-H2b mice. Mol Immunol. 2006, 43: 1332-1339. 10.1016\/j.molimm.2005.09.003.","journal-title":"Mol Immunol"},{"key":"2717_CR42","doi-asserted-by":"publisher","first-page":"2318","DOI":"10.4049\/jimmunol.179.4.2318","volume":"179","author":"CQ Nguyen","year":"2007","unstructured":"Nguyen CQ, Kim H, Cornelius JG, Peck AB: Development of Sjogren's syndrome in nonobese diabetic-derived autoimmune-prone C57BL\/6.NOD-Aec1Aec2 mice is dependent on complement component-3. J Immunol. 2007, 179: 2318-2329.","journal-title":"J Immunol"},{"key":"2717_CR43","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1084\/jem.180.3.995","volume":"180","author":"XD Yang","year":"1994","unstructured":"Yang XD, Tisch R, Singer SM, Cao ZA, Liblau RS, Schreiber RD, McDevitt HO: Effect of tumor necrosis factor alpha on insulin-dependent diabetes mellitus in NOD mice. I. The early development of autoimmunity and the diabetogenic process. J Exp Med. 1994, 180: 995-1004. 10.1084\/jem.180.3.995.","journal-title":"J Exp Med"},{"issue":"Suppl 3","key":"2717_CR44","doi-asserted-by":"publisher","first-page":"S141","DOI":"10.1186\/ar570","volume":"4","author":"H McDevitt","year":"2002","unstructured":"McDevitt H, Munson S, Ettinger R, Wu A: Multiple roles for tumor necrosis factor-alpha and lymphotoxin alpha\/beta in immunity and autoimmunity. Arthritis Res. 2002, 4 (Suppl 3): S141-152. 10.1186\/ar570.","journal-title":"Arthritis Res"},{"key":"2717_CR45","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1002\/eji.1830270138","volume":"27","author":"RE Hunger","year":"1997","unstructured":"Hunger RE, Carnaud C, Garcia I, Vassalli P, Mueller C: Prevention of autoimmune diabetes mellitus in NOD mice by transgenic expression of soluble tumor necrosis factor receptor p55. Eur J Immunol. 1997, 27: 255-261. 10.1002\/eji.1830270138.","journal-title":"Eur J Immunol"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/ar2888.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/ar2888\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/ar2888.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T11:14:45Z","timestamp":1728386085000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/ar2888"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12,14]]},"references-count":45,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2009,12]]}},"alternative-id":["2717"],"URL":"https:\/\/doi.org\/10.1186\/ar2888","relation":{},"ISSN":["1478-6354"],"issn-type":[{"value":"1478-6354","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,12,14]]},"assertion":[{"value":"17 August 2009","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2009","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2009","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2009","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"R189"}}